“…Several studies have evidenced high variability of VIA to detect high‐grade cervical lesions with sensitivities ranging between 17%‐96% in primary screening, 4 , 6 , 13 , 14 , 15 , 16 , 17 and between 25%–92% in HPV‐positive women. 13 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 Only five studies in HPV‐positive women, characterised by including intensive training, report sensitivities ≥80%. 20 , 23 , 24 , 27 , 30 VIA positivity, which is a useful indicator in triage scenarios, has also shown to be highly variable.…”